Hamburg’s Public Farewell Includes Rallying Cry For FDA Power
This article was originally published in The Pink Sheet Daily
Executive Summary
Outgoing commissioner gives forceful defense of the agency’s regulatory authority and warns that lowering drug approval standards would damage both patients and industry.